Altimmune, Inc.ALTNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank57
3Y CAGR-3.8%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

3Y CAGR
-3.8%/yr
vs -14.5%/yr prior
Acceleration
+10.6pp
Accelerating
Percentile
P57
Within normal range
vs 3Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
20258.42%
2024-7.55%
2023-9.33%
20229.47%
2021-76.85%
2020-155.29%
201949.89%
201817.70%
2017-362.04%
2016-231.03%